New heart implant aims to cut stroke risk without blood thinners
NCT ID NCT07262255
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is tracking 1000 people with atrial fibrillation who receive the WATCHMAN FLX Pro device, a small implant that closes off a part of the heart to prevent blood clots from causing strokes. The goal is to see how safe and effective the device is in everyday medical practice, especially for patients who cannot take long-term blood thinners. Researchers will monitor for serious events like stroke, bleeding, or death within a week of the procedure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
WATCHMAN FLX Pro device (a left atrial appendage closure implant)
What this could lead to
If successful, this registry could confirm that the device safely reduces stroke risk and bleeding events in people with atrial fibrillation who cannot take blood thinners.
What could go wrong
This is an observational registry, not a controlled trial, so results may not prove cause and effect. There are procedural risks like bleeding, stroke, or need for emergency surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-VALVULAR ATRIAL FIBRILLATION (AF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aarhus University Hospital
RECRUITINGAarhus, 8200, Denmark
Contact
-
Asklepios Klinik Altona
RECRUITINGHamburg, 22763, Germany
Contact
-
Asklepios Klinik Nord Heidberg
RECRUITINGHamburg, 22417, Germany
Contact
-
Asklepios Klinik Saint Georg
RECRUITINGHamburg, 20099, Germany
Contact
-
Centro Cardiologico Monzino
RECRUITINGMilan, 20138, Italy
Contact
-
Clinica Universidad de Navarra
RECRUITINGPamplona, 31008, Spain
Contact
Contact
-
Complejo Hospitalario Universitario de Pontevedra
RECRUITINGPontevedra, 36001, Spain
Contact
-
Hospital Clinico Salamanca
RECRUITINGSalamanca, 37007, Spain
Contact
-
Hospital de Leon
RECRUITINGLeón, 24071, Spain
Contact
-
INSELSPITAL - Universitätsspital Bern
RECRUITINGBern, CH-3010, Switzerland
Contact
-
Kath Krankenhaus St Johann Nepomuk
RECRUITINGErfurt, 99097, Germany
Contact
-
Rigshospitalet Copenhagen
RECRUITINGCopenhagen, 2100, Denmark
Contact
-
University Hospital Basel
RECRUITINGBasel, 4031, Switzerland
Contact
-
Uniwersytecki Szpital Kliniczny w Poznaniu
RECRUITINGPoznan, 61-848, Poland
Contact